Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
- CAMBRIDGE, Mass. & OSAKA, Japan -- Archemix Corp. ("Archemix") and Takeda Pharmaceutical Company Limited ("Takeda") announced today that both parties have signed a multi-year, three target agreement that focuses on the discovery, development and commercialization of first-in-class aptamer-based therapeutics. Under the agreement, Archemix will receive an upfront payment of...
- Research articles 2007-06-11
Additional Resources
- Cambridge, Mass., Biotech Drug Firm Lands $50 Million in Venture Funding.
- By Beth Healy, The Boston Globe Knight Ridder/Tribune Business News Apr. 6--Archemix Corp., a private drug-development start-up in Cambridge, has landed $50 million in venture capital, providing fresh evidence that investors and venture firms are eager to fund hot biotech companies. ...
- Research articles 2004-04-06
- << Previous
- page 1 of 1
- Next >>
